The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,564,028,451 units of the pharmaceutical product dactinomycin 500 mcg vials. The $3,570.00 contract has a performance period ending on March 21, 2024. AmerisourceBergen Drug Corp, located in Conshohocken, Pennsylvania, is the prime contractor for this delivery order. The award is not associated with a set-aside...
This is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 500 mcg vials of the drug dactinomycin. The contract has a ceiling value of $10,200.00 and a period of performance through November 4, 2024. The contract is a firm-fixed-price type and was not set aside for any specific business category. AmerisourceBergen, a for-profit organization, is providing these pharmaceutical products to support...
The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a Delivery Order contract worth $1,726.81 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 50 mg Doxorubicin vials. This Delivery Order contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical...
The U.S. government's Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at $5,193.87. The contract is to provide a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,046.54 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, which does not have a set-aside designation, covers the supply of a comprehensive range of medical products including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits to support military healthcare programs globally. This delivery order is part of a larger...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, for the supply of various pharmaceutical products and medical supplies. The $1,855.80 Firm Fixed Price contract has an ultimate completion date of July 24, 2024 and is not designated as a set-aside. This Delivery Order is likely part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $6,443.49 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of a variety of pharmaceutical products and medical supplies, including specialty, brand name, generic, and over-the-counter medications, as well as critical care materials such as syringes, vials, and test kits. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $14,154.86, is for the delivery of various pharmaceutical products and medical supplies to support federal healthcare programs, particularly military and veterans' healthcare systems. The contract is a firm fixed price delivery order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,564.63 to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of pharmaceutical and medical products. This contract is part of a larger Indefinite Delivery Contract (IDC) between the DLA Troop Support Medical and Amerisourcebergen's parent company, Cencora, Inc., valued at up to $999,999,999.00 and running through November 2026. The contract encompasses a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of a range of medical products and pharmaceuticals. The contract has a ceiling value of $10,750.82 and a performance period extending through May 6, 2025. The delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with DLA Troop Support Medical, valued at $999,999,999.00 and in effect through...